Schedule 13G ownership disclosure

Biotech Acquisition Co

Security class unavailable · CUSIP: G1125A124

Event date: 2021-01-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-21-001692
Form type
SC 13G
Filer
Biotech Acquisition Co
CIK
CIK 1825413
Filed
Feb 16, 2021
Reporting period
Jan 28, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub